Literature DB >> 25863248

miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling.

Xiaojun Liu1, Junjie Xiao2, Han Zhu1, Xin Wei1, Colin Platt1, Federico Damilano1, Chunyang Xiao1, Vassilios Bezzerides3, Pontus Boström4, Lin Che5, Chunxiang Zhang6, Bruce M Spiegelman7, Anthony Rosenzweig8.   

Abstract

Exercise induces physiological cardiac growth and protects the heart against pathological remodeling. Recent work suggests exercise also enhances the heart's capacity for repair, which could be important for regenerative therapies. While microRNAs are important in certain cardiac pathologies, less is known about their functional roles in exercise-induced cardiac phenotypes. We profiled cardiac microRNA expression in two distinct models of exercise and found microRNA-222 (miR-222) was upregulated in both. Downstream miR-222 targets modulating cardiomyocyte phenotypes were identified, including HIPK1 and HMBOX1. Inhibition of miR-222 in vivo completely blocked cardiac and cardiomyocyte growth in response to exercise while reducing markers of cardiomyocyte proliferation. Importantly, mice with inducible cardiomyocyte miR-222 expression were resistant to adverse cardiac remodeling and dysfunction after ischemic injury. These studies implicate miR-222 as necessary for exercise-induced cardiomyocyte growth and proliferation in the adult mammalian heart and show that it is sufficient to protect the heart against adverse remodeling.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25863248      PMCID: PMC4393846          DOI: 10.1016/j.cmet.2015.02.014

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  50 in total

1.  C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling.

Authors:  Pontus Boström; Nina Mann; Jun Wu; Pablo A Quintero; Eva R Plovie; Daniela Panáková; Rana K Gupta; Chunyang Xiao; Calum A MacRae; Anthony Rosenzweig; Bruce M Spiegelman
Journal:  Cell       Date:  2010-12-23       Impact factor: 41.582

2.  Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter.

Authors:  Atsushi Sanbe; James Gulick; Mark C Hanks; Qiangrong Liang; Hanna Osinska; Jeffrey Robbins
Journal:  Circ Res       Date:  2003-03-06       Impact factor: 17.367

3.  Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus.

Authors:  H van Praag; G Kempermann; F H Gage
Journal:  Nat Neurosci       Date:  1999-03       Impact factor: 24.884

4.  Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.

Authors:  Gabriella D'Orazi; Barbara Cecchinelli; Tiziana Bruno; Isabella Manni; Yuichiro Higashimoto; Shin'ichi Saito; Monica Gostissa; Sabrina Coen; Alessandra Marchetti; Giannino Del Sal; Guilia Piaggio; Maurizio Fanciulli; Ettore Appella; Silvia Soddu
Journal:  Nat Cell Biol       Date:  2002-01       Impact factor: 28.824

5.  Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo.

Authors:  T Matsui; J Tao; F del Monte; K H Lee; L Li; M Picard; T L Force; T F Franke; R J Hajjar; A Rosenzweig
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

6.  Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart.

Authors:  Takashi Matsui; Ling Li; Justina C Wu; Stuart A Cook; Tomohisa Nagoshi; Michael H Picard; Ronglih Liao; Anthony Rosenzweig
Journal:  J Biol Chem       Date:  2002-04-09       Impact factor: 5.157

7.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

8.  A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.

Authors:  M L Fero; M Rivkin; M Tasch; P Porter; C E Carow; E Firpo; K Polyak; L H Tsai; V Broudy; R M Perlmutter; K Kaushansky; J M Roberts
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

9.  Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

Authors:  H Kiyokawa; R D Kineman; K O Manova-Todorova; V C Soares; E S Hoffman; M Ono; D Khanam; A C Hayday; L A Frohman; A Koff
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

10.  The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation.

Authors:  Cheryl D Waring; Carla Vicinanza; Angela Papalamprou; Andrew J Smith; Saranya Purushothaman; David F Goldspink; Bernardo Nadal-Ginard; Daniele Torella; Georgina M Ellison
Journal:  Eur Heart J       Date:  2012-10-25       Impact factor: 29.983

View more
  150 in total

1.  CITED4 induces physiologic hypertrophy and promotes functional recovery after ischemic injury.

Authors:  Vassilios J Bezzerides; Colin Platt; Carolin Lerchenmüller; Kaavya Paruchuri; Nul Loren Oh; Chunyang Xiao; Yunshan Cao; Nina Mann; Bruce M Spiegelman; Anthony Rosenzweig
Journal:  JCI Insight       Date:  2016-06-16

Review 2.  Influence of Physical Activity on Hypertension and Cardiac Structure and Function.

Authors:  Sheila M Hegde; Scott D Solomon
Journal:  Curr Hypertens Rep       Date:  2015-10       Impact factor: 5.369

Review 3.  Redirecting cardiac growth mechanisms for therapeutic regeneration.

Authors:  Ravi Karra; Kenneth D Poss
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

4.  Noncoding RNAs regulating cardiac muscle mass.

Authors:  Glenn D Wadley; Séverine Lamon; Sarah E Alexander; Julie R McMullen; Bianca C Bernardo
Journal:  J Appl Physiol (1985)       Date:  2018-12-20

Review 5.  Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.

Authors:  Roopesh S Gangwar; Sanjay Rajagopalan; Rama Natarajan; Jeffrey A Deiuliis
Journal:  Am J Hypertens       Date:  2018-01-12       Impact factor: 2.689

Review 6.  Targeting Age-Related Pathways in Heart Failure.

Authors:  Haobo Li; Margaret H Hastings; James Rhee; Lena E Trager; Jason D Roh; Anthony Rosenzweig
Journal:  Circ Res       Date:  2020-02-13       Impact factor: 17.367

Review 7.  Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs.

Authors:  Tiago Fernandes; Valério G Baraúna; Carlos E Negrão; M Ian Phillips; Edilamar M Oliveira
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-12       Impact factor: 4.733

Review 8.  Exercise in Heart Failure-What Is the Optimal Dose to Improve Pathophysiology and Exercise Capacity?

Authors:  Michael Johannes Schindler; Volker Adams; Martin Halle
Journal:  Curr Heart Fail Rep       Date:  2019-08

Review 9.  Cardiac adaptation to exercise training in health and disease.

Authors:  Dae Yun Seo; Hyo-Bum Kwak; Amy Hyein Kim; Se Hwan Park; Jun Won Heo; Hyoung Kyu Kim; Jeong Rim Ko; Sam Jun Lee; Hyun Seok Bang; Jun Woo Sim; Min Kim; Jin Han
Journal:  Pflugers Arch       Date:  2019-04-23       Impact factor: 3.657

10.  BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.

Authors:  Qiming Duan; Sarah McMahon; Priti Anand; Hirsh Shah; Sean Thomas; Hazel T Salunga; Yu Huang; Rongli Zhang; Aarathi Sahadevan; Madeleine E Lemieux; Jonathan D Brown; Deepak Srivastava; James E Bradner; Timothy A McKinsey; Saptarsi M Haldar
Journal:  Sci Transl Med       Date:  2017-05-17       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.